Document Preview Unavailable

Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis

Matsumoto, Hiromi; Somekawa Kohei; Horita Nobuyuki; Ueda Suguru; Kaneko Megumi; et al.  Therapeutic Advances in Medical Oncology Vol. 15,  (Jan 2023).

You might have access to this document